Sign in
CNC-CENTENE CORP

Centene Reaffirms 2024 Guidance with Strong EPS Projections Amid Market Fluctuations and Industry Challenges

Saturday

21 December, 2024

Centene Corporation is navigating a complex health insurance landscape with a strong EPS forecast, projecting over $6.80 for 2024 and exceeding $7.25 for 2025. Can the company maintain its momentum amidst industry challenges and shifting market sentiments?

article image for CNC

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
79
Key Takeaways
  • Centene Corporation forecasts adjusted EPS exceeding $6.80 for 2024 and $7.25 for 2025.
  • The company's stock has rebounded due to a 10% revenue increase to $42 billion.
  • Growth in Marketplace membership and Medicare Prescription Drug Plans highlights positive trends despite Medicaid challenges.
  • CFO Andrew Asher's $1 million stock purchase reflects strong confidence in the company's future.
  • Centene's strategic initiatives and financial outlook suggest potential for significant investor returns.
More on CENTENE CORP
Read more insights on CENTENE CORP

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.